Roger Medel Net Worth

The estimated Net Worth of Roger Md Medel is at least 67.7 百万$ dollars as of 10 January 2022. Roger Medel owns over 100,000 units of Pediatrix Medical Inc stock worth over 7,845,565$ and over the last 15 years he sold MD stock worth over 51,772,125$. In addition, he makes 8,066,280$ as Director at Pediatrix Medical Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Roger Medel MD stock SEC Form 4 insiders trading

Roger has made over 32 trades of the Pediatrix Medical Inc stock since 2009, according to the Form 4 filled with the SEC. Most recently he sold 100,000 units of MD stock worth 2,650,000$ on 10 January 2022.

The largest trade he's ever made was exercising 200,000 units of Pediatrix Medical Inc stock on 13 November 2013 worth over 6,198,000$. On average, Roger trades about 37,790 units every 71 days since 2009. As of 10 January 2022 he still owns at least 739,450 units of Pediatrix Medical Inc stock.

You can see the complete history of Roger Medel stock trades at the bottom of the page.

Roger Medel biography

Dr. Roger J. Medel M.D. serves as Director of the Company. Dr. Medel has been a Director of the Company since he co-founded it in 1979. Dr. Medel served as the Company’s President until May 2000 and as Chief Executive Officer until December 2002. In March 2003, Dr. Medel reassumed the position of President, serving in that position until May 2004, and Chief Executive Officer, a position in which he continues to serve today. Dr. Medel has served as a member of the Board of Trustees of the Dana Farber Cancer Institute, Inc. since January 2016. Dr. Medel was a member of the Board of Trustees of the University of Miami from January 2004 to February 2012. Dr. Medel participates as a member of several medical and professional organizations and, from June 2006 to April 2009, served on the Board of Directors of MBF Healthcare Acquisition Corp. The Board of Directors has concluded that Dr. Medel’s qualifications to serve on the Board include his experience as our Chief Executive Officer and founder of the Company and a physician with training and experience in the Company’s historical base service line of neonatology.

What is the salary of Roger Medel?

As the Director of Pediatrix Medical Inc, the total compensation of Roger Medel at Pediatrix Medical Inc is 8,066,280$. There are no executives at Pediatrix Medical Inc getting paid more.

How old is Roger Medel?

Roger Medel is 73, he's been the Director of Pediatrix Medical Inc since 2020. There are 1 older and 19 younger executives at Pediatrix Medical Inc. The oldest executive at Pediatrix Medical Group Inc is Dr. Roger J. Medel, 74, who is the Co-Founder & Director.

What's Roger Medel's mailing address?

Roger's mailing address filed with the SEC is 1301, Concord Terrace, Sunrise, Weston, Broward County, Florida, 33323, United States.

Insiders trading at Pediatrix Medical Inc

Over the last 16 years, insiders at Pediatrix Medical Inc have traded over 151,130,633$ worth of Pediatrix Medical Inc stock and bought 737,264 units worth 19,901,767$ . The most active insiders traders include Roger Md Medel、Manuel Kadre、Michael Fernandez. On average, Pediatrix Medical Inc executives and independent directors trade stock every 25 days with the average trade being worth of 297,048$. The most recent stock trade was executed by James D Swift on 30 August 2024, trading 11,100 units of MD stock currently worth 119,769$.

What does Pediatrix Medical Inc do?

mednax is a physician-led health solutions partner providing the highest quality patient care through our national network of nearly 3,000 physicians. our physician practices and business professionals are passionate about taking great care of patients, continually optimizing performance and helping providers overcome healthcare’s quality, financial and administrative complexities. physicians and advanced practitioners practicing as part of mednax are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research to enhance patient outcomes and provide high-quality, cost-effective care. the company was founded in 1979, and today, through its affiliated professional corporations, mednax provides services through a network of more than 3,200 physicians in all 50 states and puerto rico. in addition to its national physician network, mednax provides services to healthcare facilities and physicians in

Complete history of Roger Medel stock trades at Opko Health Inc、Pediatrix Medical Inc

Pediatrix Medical Inc executives and stock owners

Pediatrix Medical Inc executives and other stock owners filed with the SEC include:

• Roger Medel,
  Director
• John Pepia,
  Senior Vice President, Chief Accounting Officer
• Dominic Andreano,
  Executive Vice President, General Counsel, Secretary
• Dr. Roger J. Medel,
  Co-Founder & Director
• Mark S. Ordan,
  CEO & Director
• Dr. Roger Mack Hinson M.D.,
  Pres of Pediatrix & Obstetrix Medical Groups
• Dominic J. Andreano,
  Exec. VP, Gen. Counsel & Sec.
• John C. Pepia,
  Sr. VP & Chief Accounting Officer
• C. Marc Richards,
  Exec. VP, CFO & Principal Accounting Officer
• Michael Rucker,
  Independent Director
• Manuel Kadre,
  Lead Independent Director
• Paul Gabos,
  Independent Director
• Waldemar Carlo,
  Independent Director
• Karey Barker,
  Independent Director
• Charles Lynch,
  Vice President, Strategy and Investor Relations
• Shirley Weis,
  Independent Director
• John Starcher,
  Independent Director
• Thomas McEachin,
  Independent Director
• Nikos Nikolopoulos,
  Executive Vice President, Chief Strategy and Growth Officer
• C. Marc Richards,
  Chief Financial Officer, Executive Vice President
• Mark Ordan,
  Chief Executive Officer
• Guy Sansone,
  Independent Chairman of the Board
• Claire M. Fair,
  Sr. VP & Chief HR Officer
• Dr. James D. Swift M.D.,
  Chief Devel. Officer
• Dana Dreher-Rodwell,
  VP & Chief Compliance Officer
• Charles W. Lynch C.F.A.,
  Sr. VP of Fin., Strategy & Investor Relations
• Sylvia Jean Young,
  
• Donna E Shalala,
  Director
• Cesar L Alvarez,
  Director
• Michael D Stanley,
  President, Pediatrix Division
• Karl B Wagner,
  Chief Financial Officer
• Md Pascal J Goldschmidt,,
  Director
• Enrique Sosa,
  Director
• Vivian Lopez Blanco,
  Chief Financial Officer
• Michael Fernandez,
  Director
• Nicholas J Nikolopoulos,
  EVP Chf Strategy & Growth Offi
• David A. Clark,
  Chief Operating Officer
• Joseph M Calabro,
  President and COO
• Laura A Linynsky,
  
• Roger K Freeman,
  Director
• William C Hawk,
  COO American Anesthesiology
• Thomas W Hawkins,
  SVP, General Counsel and Secy.
• Frederick V Miller,
  President, Pediatrix Division
• Dany Garcia,
  Director
• Carlos A Migoya,
  Director
• Stephen D Farber,
  Former Chief Financial Officer
• Roger Mack Hinson,
  Pres., PDX & OBX Medical Group
• Mary Ann E Moore,
  EVP, General Counsel & Sec
• Curtis Pickert,
  EVP, Chief Operating Officer
• James D Swift,
  Chief Executive Officer
• Lee Wood,
  EVP, Natl & Market Operations